Lista de obras - Peter Quehenberger - Dominio Público Uruguay

A patient with sudden abdominal pain 10 years after successful renal transplantation

artículo científico publicado en 2003

Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent

artículo científico publicado en 2015

An experimental model to study isolated effects of thrombin in vivo

artículo científico publicado en 2010

Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban

artículo científico publicado en 2015

Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies

artículo científico publicado en 2008

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

artículo científico publicado en 2017

Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.

artículo científico publicado en 2006

Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients

artículo científico publicado en 2007

Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice

artículo científico publicado en 2007

Dabigatran: patient management in specific clinical settings

artículo científico publicado en 2014

Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow

artículo científico publicado en 2016

Endothelial cell activation and blood coagulation in critically ill patients with lung injury.

artículo científico publicado en 2002

Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia

artículo científico publicado en 2006

FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors

artículo científico publicado en 2016

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

artículo científico publicado en 2016

Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions

artículo científico publicado en 2002

High D-dimer levels are associated with poor prognosis in cancer patients

artículo científico publicado en 2012

High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant

artículo científico publicado en 2007

High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting

artículo científico publicado en 2004

Homozygous antithrombin deficiency type II causing neonatal thrombosis

artículo científico publicado en 2017

Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests ⬇️

artículo científico publicado el 1 de enero de 2012

Interspecies differences in coagulation profile

Laboratory methods in the haemostatic laboratory

Leptin induces endothelin-1 in endothelial cells in vitro

artículo científico publicado en 2002

Lupus-anticoagulant testing at NOAC trough levels

artículo científico publicado en 2016

Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry.

artículo científico publicado en 2014

Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion

artículo científico publicado en 2011

Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation

artículo científico publicado en 2018

Platelet dysfunction in outpatients with left ventricular assist devices

artículo científico publicado en 2009

Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation

artículo científico publicado en 2002

Prediction of venous thromboembolism in cancer patients

artículo científico publicado en 2010

Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?

artículo científico publicado en 2005

Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin

artículo científico publicado en 2004

Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers

artículo científico publicado en 2013

Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

artículo científico publicado en 2013

Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers

artículo científico publicado en 2011

Superficial thrombophlebitis and risk for recurrent venous thromboembolism

artículo científico publicado en 2003

Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study

artículo científico publicado en 2017

The course of anticardiolipin antibody levels under immunoadsorption therapy

artículo científico publicado en 2005

The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism.

artículo científico publicado en 2003

The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial

artículo científico publicado en 2010

The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo

artículo científico publicado en 2007

The formation of platelet-leukocyte aggregates varies during the menstrual cycle

artículo científico publicado en 2006

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism

artículo científico publicado en 2004

Tissue factor exposing microparticles in inflammatory bowel disease ⬇️

artículo científico publicado el 15 de junio de 2012

Vitamin C inhibits NO-induced stabilization of HIF-1alpha in HUVECs

artículo científico publicado en 2010

Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications

artículo científico publicado en 2017

von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy

artículo científico publicado en 2016

Lista de obras de Peter Quehenberger

A patient with sudden abdominal pain 10 years after successful renal transplantation

Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent

An experimental model to study isolated effects of thrombin in vivo

Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban

Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.

Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients

Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice

Dabigatran: patient management in specific clinical settings

Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow

Endothelial cell activation and blood coagulation in critically ill patients with lung injury.

Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia

FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions

High D-dimer levels are associated with poor prognosis in cancer patients

High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant

High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting

Homozygous antithrombin deficiency type II causing neonatal thrombosis

Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests ⬇️

Interspecies differences in coagulation profile

Interspecies differences in coagulation profile

Laboratory methods in the haemostatic laboratory

Leptin induces endothelin-1 in endothelial cells in vitro

Lupus-anticoagulant testing at NOAC trough levels

Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry.

Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion

Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation

Platelet dysfunction in outpatients with left ventricular assist devices

Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation

Prediction of venous thromboembolism in cancer patients

Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?

Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin

Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers

Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers

Superficial thrombophlebitis and risk for recurrent venous thromboembolism

Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study

The course of anticardiolipin antibody levels under immunoadsorption therapy

The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism.

The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial

The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo

The formation of platelet-leukocyte aggregates varies during the menstrual cycle

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism

Tissue factor exposing microparticles in inflammatory bowel disease ⬇️

Vitamin C inhibits NO-induced stabilization of HIF-1alpha in HUVECs

Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications

von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy